{"id":52508,"date":"2023-01-04T12:02:24","date_gmt":"2023-01-04T11:02:24","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/active-pharmaceutical-ingredient-global-market-report-2023-high-adoption-rate-of-generic-drugs-bolsters-sector-researchandmarkets-com\/"},"modified":"2023-01-04T12:02:24","modified_gmt":"2023-01-04T11:02:24","slug":"active-pharmaceutical-ingredient-global-market-report-2023-high-adoption-rate-of-generic-drugs-bolsters-sector-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/active-pharmaceutical-ingredient-global-market-report-2023-high-adoption-rate-of-generic-drugs-bolsters-sector-researchandmarkets-com\/","title":{"rendered":"Active Pharmaceutical Ingredient Global Market Report 2023: High Adoption Rate of Generic Drugs Bolsters Sector – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “Active Pharmaceutical Ingredient Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028: Segmented By Type of Synthesis, By Type of Manufacturer, By Route of Administration, By Route of Administration, By Therapeutic Application, By Region”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nThe global active pharmaceutical ingredient market is expected to undergo robust growth during the forecast period, 2024-2028. The high adoption rate of generic drugs and increasing demand for specialty medicines are bolstering the growth of the market. The expansion of biopharmaceutical sector along with development of new drugs using active pharmaceutical ingredients are expected to propel the growth of the market. Additionally, rising prevalence of chronic and infectious diseases such as cancer, diabetes, hepatitis A, influenza, among others are surging the market growth.\n<\/p>\n

\nThere is a rise in number of people suffering from these diseases, due to which demand for API’s are growing, which, in turn, propel the growth of the market globally. According to the WHO, Cancer is a prominent cause of death worldwide, accounting for approximately 10 million deaths in 2020. The most common cancer was breast cancer with 2.26 million new cases, and lung cancer with 2.21 million new cases.\n<\/p>\n

\nMoreover, rapid advancements in active pharmaceutical ingredient (API) manufacturing are supporting the market growth. The increasing cases of congenital heart diseases and obesity are also anticipated to drive the market growth through 2028. However, shortening the drug development time and reducing the cost of development are some key issues API manufacturers need to handle, otherwise, it may slow down the growth of the market.\n<\/p>\n

\nGlobal active pharmaceutical ingredient market is segmented into type of synthesis, type of manufacturer, route of administration, type of drug, therapeutic application and region. Based on type of manufacturer, the market is segmented into in-house and contract. Among them, the in-house manufacturer segment is expected to dominate the market during the forecast period as innovator companies are increasingly preferring in-house manufacturing to avail economic benefit and prevent technology leakage.\n<\/p>\n

\nRegionally, North America dominated the global active pharmaceutical ingredient market in 2022 and is further expected to continue its dominance during the forecast period. The presence of adequate manufacturing units and technological advancement in the region are acting as key growth drivers for the market.\n<\/p>\n

\nMajor companies operating in global active pharmaceutical ingredient market include Teva Pharmaceutical Industries Ltd., Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH, Merck & Co., Inc., GlaxoSmithKline Plc, Novartis International AG, F. Hoffmann-La Roche AG, Sanofi S.A., Eli Lilly and Company, and AbbVie Inc. The market players are investing on new product launches through extensive R&D activities. They are also undergoing partnerships, merger and collaborations to increase their share in global market.\n<\/p>\n

\nReport Scope:<\/strong>\n<\/p>\n

\nGlobal Active Pharmaceutical Ingredient Market, By Type of Synthesis:<\/strong>\n<\/p>\n